Kathleen Kahler Fonda

Array ( [id] => 4326365 [patent_doc_number] => 06329351 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Semi-synthetic sulphaminoheparosansulphates having high anti-metastatic activity and reduced haemorrhagic risk' [patent_app_type] => 1 [patent_app_number] => 9/254128 [patent_app_country] => US [patent_app_date] => 1999-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2489 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329351.pdf [firstpage_image] =>[orig_patent_app_number] => 254128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4277100 [patent_doc_number] => 06281197 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Cardiac glycosides and their aglycone derivatives treat complications of diabetes' [patent_app_type] => 1 [patent_app_number] => 9/466036 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 12392 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281197.pdf [firstpage_image] =>[orig_patent_app_number] => 466036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1349867 [patent_doc_number] => 06579978 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Biomaterials comprising N-sulphated hyaluronic acid compounds or derivatives thereof' [patent_app_type] => B1 [patent_app_number] => 09/402510 [patent_app_country] => US [patent_app_date] => 1999-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6656 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579978.pdf [firstpage_image] =>[orig_patent_app_number] => 09402510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1348276 [patent_doc_number] => 06579858 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Use of low-molecular-weight heparins for the prevention and treatment of cerebral edemas' [patent_app_type] => B1 [patent_app_number] => 09/450110 [patent_app_country] => US [patent_app_date] => 1999-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2291 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579858.pdf [firstpage_image] =>[orig_patent_app_number] => 09450110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261708 [patent_doc_number] => 06664243 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Benzyllactobionamides as inhibitors of smooth muscle cell proliferation' [patent_app_type] => B1 [patent_app_number] => 09/444736 [patent_app_country] => US [patent_app_date] => 1999-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6288 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 250 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664243.pdf [firstpage_image] =>[orig_patent_app_number] => 09444736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404571 [patent_doc_number] => 06299897 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Inhibition of selectin binding' [patent_app_type] => 1 [patent_app_number] => 9/440880 [patent_app_country] => US [patent_app_date] => 1999-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 19080 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/299/06299897.pdf [firstpage_image] =>[orig_patent_app_number] => 440880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1585997 [patent_doc_number] => 06358930 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Treatment of C. difficile toxin B associated conditions' [patent_app_type] => B1 [patent_app_number] => 09/433944 [patent_app_country] => US [patent_app_date] => 1999-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 8717 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358930.pdf [firstpage_image] =>[orig_patent_app_number] => 09433944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409531 [patent_doc_number] => 06172206 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Crystalline form of morphine-6-glucuronide' [patent_app_type] => 1 [patent_app_number] => 9/433555 [patent_app_country] => US [patent_app_date] => 1999-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2361 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 261 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/172/06172206.pdf [firstpage_image] =>[orig_patent_app_number] => 433555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1595136 [patent_doc_number] => 06384021 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Heparin compositions of very low molecular weight' [patent_app_type] => B1 [patent_app_number] => 09/433409 [patent_app_country] => US [patent_app_date] => 1999-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2142 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384021.pdf [firstpage_image] =>[orig_patent_app_number] => 09433409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4328751 [patent_doc_number] => 06319909 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Liquid iodophor from poly-n-vinyl lactam, dextrin and alcohols' [patent_app_type] => 1 [patent_app_number] => 9/403637 [patent_app_country] => US [patent_app_date] => 1999-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3218 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319909.pdf [firstpage_image] =>[orig_patent_app_number] => 403637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4155261 [patent_doc_number] => 06107282 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Treatment of C. difficile toxin B associated conditions' [patent_app_type] => 1 [patent_app_number] => 9/419790 [patent_app_country] => US [patent_app_date] => 1999-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8777 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107282.pdf [firstpage_image] =>[orig_patent_app_number] => 419790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4271577 [patent_doc_number] => 06245744 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use' [patent_app_type] => 1 [patent_app_number] => 9/410084 [patent_app_country] => US [patent_app_date] => 1999-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8087 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 578 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245744.pdf [firstpage_image] =>[orig_patent_app_number] => 410084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4326252 [patent_doc_number] => 06329344 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Derivatives of monosaccharides as cell adhesion inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/411357 [patent_app_country] => US [patent_app_date] => 1999-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18988 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329344.pdf [firstpage_image] =>[orig_patent_app_number] => 411357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4140708 [patent_doc_number] => 06060453 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose' [patent_app_type] => 1 [patent_app_number] => 9/394434 [patent_app_country] => US [patent_app_date] => 1999-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10513 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060453.pdf [firstpage_image] =>[orig_patent_app_number] => 394434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1403821 [patent_doc_number] => 06534481 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same' [patent_app_type] => B1 [patent_app_number] => 09/230139 [patent_app_country] => US [patent_app_date] => 1999-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36564 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534481.pdf [firstpage_image] =>[orig_patent_app_number] => 09230139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260872 [patent_doc_number] => 06258798 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Method for treatment of unstable coronary artery disease by an early revascularisation together with administration of a low molecular weight heparin' [patent_app_type] => 1 [patent_app_number] => 9/391248 [patent_app_country] => US [patent_app_date] => 1999-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3033 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258798.pdf [firstpage_image] =>[orig_patent_app_number] => 391248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4277176 [patent_doc_number] => 06281202 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Pharmaceutical compositions for treatment of EGF receptor associated cancers' [patent_app_type] => 1 [patent_app_number] => 9/379016 [patent_app_country] => US [patent_app_date] => 1999-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12964 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281202.pdf [firstpage_image] =>[orig_patent_app_number] => 379016 [rel_patent_id] =>[rel_patent_doc_number] =>)